Trophoblast proliferation rate does not predict progression to persistent gestational trophoblastic disease in complete hydatidiform mole

被引:18
作者
Jeffers, MD [1 ]
Richmond, JA [1 ]
Smith, R [1 ]
机构
[1] NINEWELLS HOSP & MED SCH,DEPT OBSTET & GYNAECOL,HYDATIDIFORM MOLE FOLLOW UP UNIT,DUNDEE,SCOTLAND
关键词
hydatidiform mole; persistent gestational trophoblastic disease; Ki67; proliferation; trophoblast; prognosis;
D O I
10.1097/00004347-199601000-00006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Persistent gestational trophoblastic disease (PGTD) is a significant complication of complete hydatidiform mole. There are, however, no reliable clinical or pathological parameters to predict the development of PGTD following the evacuation of a complete mole. In this study we examined the value of Ki67 expression in the prediction of PGTD following complete mole. Immunohistochemistry for Ki67 was performed on 21 cases of complete mole complicated by PGTD and 17 cases that resolved spontaneously after evacuation. Strong Ki67 expression was seen in both villous cytotrophoblast and extravillous trophoblast of the complete moles. The Ki67 index of extravillous trophoblast was significantly higher than that of villous cytotrophoblast. There was no significant difference in Ki67 index of either villous cytotrophoblast or extravillous trophoblast between cases of complete mole complicated by PGTD and those that resolved spontaneously. Trophoblast proliferation rate does not predict outcome following complete hydatidiform mole. Other factors involved in myometrial invasion may be of importance in the development of this complication, but serum chorionic gonadotrophin level is the only reliable predictor of the development of persistent gestational trophoblastic disease.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 41 条
[1]   GESTATIONAL TROPHOBLASTIC TUMORS FOLLOWING INITIAL DIAGNOSIS OF PARTIAL HYDATIDIFORM MOLE [J].
BAGSHAWE, KD ;
LAWLER, SD ;
PARADINAS, FJ ;
DENT, J ;
BROWN, P ;
BOXER, GM .
LANCET, 1990, 335 (8697) :1074-1076
[2]  
BERKOWITZ RS, 1979, LANCET, V2, P804
[3]  
BERKOWITZ RS, 1983, OBSTET GYNECOL, V66, P677
[4]   KI67 IMMUNOSTAINING IN PRIMARY BREAST-CANCER - PATHOLOGICAL AND CLINICAL ASSOCIATIONS [J].
BOUZUBAR, N ;
WALKER, KJ ;
GRIFFITHS, K ;
ELLIS, IO ;
ELSTON, CW ;
ROBERTSON, JFR ;
BLAMEY, RW ;
NICHOLSON, RI .
BRITISH JOURNAL OF CANCER, 1989, 59 (06) :943-947
[5]  
CAMERON B, 1994, AM J OBSTET GYNECOL, V170, P1616
[6]   ASSESSMENT OF CELL-PROLIFERATION IN HYDATIDIFORM MOLE USING MONOCLONAL-ANTIBODY MIB1 TO KI-67 ANTIGEN [J].
CHEUNG, ANY ;
NGAN, HYS ;
COLLINS, RJ ;
WONG, YL .
JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (07) :601-604
[7]   THE SIGNIFICANCE OF PROLIFERATING CELL NUCLEAR ANTIGEN IN HUMAN TROPHOBLASTIC DISEASE - AN IMMUNOHISTOCHEMICAL STUDY [J].
CHEUNG, ANY ;
NGAN, HYS ;
CHEN, WZ ;
LOKE, SL ;
COLLINS, RJ .
HISTOPATHOLOGY, 1993, 22 (06) :565-568
[8]   DISTRIBUTION PATTERNS OF EXTRACELLULAR-MATRIX COMPONENTS AND ADHESION RECEPTORS ARE INTRICATELY MODULATED DURING 1ST TRIMESTER CYTOTROPHOBLAST DIFFERENTIATION ALONG THE INVASIVE PATHWAY, INVIVO [J].
DAMSKY, CH ;
FITZGERALD, ML ;
FISHER, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01) :210-222
[9]   PARTIAL HYDATIDIFORM MOLES - DEOXYRIBONUCLEIC-ACID CONTENT AND COURSE [J].
DAVIS, JR ;
KERRIGAN, DP ;
WAY, DL ;
WEINER, SA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 157 (04) :969-973
[10]   PROGNOSTIC-SIGNIFICANCE OF KI-67 IMMUNOSTAINING IN NONMETASTATIC RENAL-CELL CARCINOMA [J].
DERIESE, WTW ;
CRABTREE, WN ;
ALLHOFF, EP ;
WERNER, M ;
LIEDKE, S ;
LENIS, G ;
ATZPODIEN, J ;
KIRCHNER, H .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) :1804-1808